Cellular Uptake and Efflux of Palbociclib In Vitro in Single Cell and Spheroid Models

Abstract

Adequate drug distribution through tumours is essential for treatment to be effective. Palbociclib is a cyclin-dependent kinase (CDK) 4/6 inhibitor approved for use in patients with hormone receptor (HR) positive, HER2 negative metastatic breast cancer (BC). It has unusual physicochemical properties, which may significantly influence its distribution in tumour tissue. We studied the penetration and distribution of palbociclib in vitro, including the use of multicellular three-dimensional models and mathematical modelling. MCF-7 and DLD-1 cell lines were grown as single cell suspensions (SCS) and spheroids; palbociclib uptake and efflux were studied using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Intracellular concentrations of palbociclib for MCF-7 SCS (C max 3.22µM) and spheroids (C max 2.91 µM) were 32 and 29 fold higher and in DLD-1, 13 and 7 fold higher, respectively than the media concentration (0.1 μM). Total palbociclib uptake was lower in DLD-1 cells than MCF-7 cells both in SCS and in spheroids. Both uptake and efflux of palbociclib were slower in spheroids than SCS. These data were used to develop a mathematical model of palbociclib transport that quantifies key parameters determining drug penetration and distribution. The model reproduced qualitatively most features of the experimental data and distinguished between SCS and spheroids, providing additional support for hypotheses derived from the experimental data. Mathematical modelling has the potential for translating in vitro data into clinically relevant estimates of tumour drug concentrations. Significance statement This study explores palbociclib uptake and efflux in single cell suspension and spheroid models of cancer. Large intracellular concentrations of palbociclib are found after drug exposure. The data from this study may aid understanding of the intratumoural pharmacokinetics of palbociclib which is useful in understanding how drug distributes within This article has not been copyedited and formatted. The final version may differ from this version.

Spheroid-Based Approach to Assess the Tissue Relevance of Analysis of Dispersed-Settled Tissue Cells by Cytometry of the Reaction Rate Constant

“…66 In this light, the formation of a drug-resistant subpopulation within spheroids is a clinically important event, which can be determined by CRRC but cannot be detected by currently used assays based on whole spheroids. 67…”

“…On the other hand, they can model well ascitic spheroids in ovarian cancer metastases, pleural spheroids in lung cancer, and circulating spheroids in other cancer types. − In particular, ascites containing a mixture of spheroids and individual cancer cells are present in almost all patients with recurrent disease and represent a major pathway of cancer dissemination . In this light, the formation of a drug-resistant subpopulation within spheroids is a clinically important event, which can be determined by CRRC but cannot be detected by currently used assays based on whole spheroids …”

Quantifying the role of different surface coatings in experimental models of wound healing

“…Mathematical models have been applied to mimic both in vitro and in vivo experiments to test biological hypotheses and to predict experimental outcomes (Jin et al, 2018a;Jove et al, 2019;Nardini et al, 2016;Sheardown and Cheng, 1996;Tam et al, 2019;Villella et al, 2019). One of the most commonly used models to study collective cell migration is the Fisher-Kolmogorov model (Fisher, 1937;Maini et al, 2004;Sherratt and Murray, 1990;Simpson et al, 2006).…”

High‐throughput CRISPR‐mediated 3D enrichment platform for functional interrogation of chemotherapeutic resistance

“…CDK4/6i drugs have been shown to preferentially accumulate in the acidic lysosomes of cancer cells, which further acts as a storage depot for the temporal release of the drug (Llanos et al, 2019). It is tempting to speculate that this preferential accumulation of the drug concentrates higher amounts of it in certain locations of the spheroid (spheroid shell) leading to a decreased gradient of drug towards the core of the spheroid, resulting in increased resistance in 3D (Bacevic et al, 2017; Jove et al, 2021). Similar observations of differential drug sensitivity in 2D versus 3D have been noticed across multiple cancers and constitute one of the important features of 3D screening systems to mimic in vivo relevant drug sensitivities (Imamura et al, 2015).…”